Open Accessibility Menu

Pradaxa Defective Drug Lawsuits Starting to Take off

The Law Offices of Tyler & Peery

According to the American Bar Association Journal, lawyers have filed exactly 131 cases against Boehringer Ingelheim, the global drug maker based in Germany, and one of the largest pharmaceutical companies in the world. These suits allege that Boehringer Ingelheim's drug Pradaxa is a defective drug that has caused serious injuries and deaths among patients.

Pradaxa is used to prevent drug clots in patients with cardiac arrhythmia.

The problem with Pradaxa is it has been touted by Boehringer Ingelheim's marketing and sales arm as a new-and-improved alternative to warfarin, a drug that has been on the market for decades. Doctors and health care professionals understand how to administer warfarin and minimize the risk associated with the drug.

Specifically, the Pradaxa lawsuits allege a failure to warn of risks, as well as Boehringer Ingelheim's failure to provide an effective antidote in the case of a major bleeding event in a patient. As it has happened in some cases, bleeding caused by Pradaxa has been irreversible.

For its part, Boehringer Ingelheim cites a FDA report stating that Pradaxa is essentially no worse than warfarin. This may be true, but has little relation to Boehringer Ingelheim's marketing and sales practices.

Source: More Than 100 Suits Filed over Pradaxa Warnings

Categories:

Request Your
Free Consultation

  • Please enter your first name.
  • Please enter your last name.
  • This isn't a valid phone number.
    Please enter your phone number.
    You entered an invalid number.
  • This isn't a valid email address.
    Please enter your email address.
  • Please make a selection.
  • Please enter a message.
Why Choose Our Firm?
  • 100+ Years of Combined Experience
  • You Don’t Pay Unless We Win
  • Home & Hospital Visits Available
  • Millions of Dollars Recovered
  • Se Habla Español